Translational andrology and urology
Impact of durable response of first-line systemic treatment for patients with locally advanced or metastatic urothelial carcinoma: data update of EV-302/KEYNOTE-A39 trial.
Makito Miyake
Published: 202510.21037/tau-2025-587
No abstract available for this study.